Enzymatica AB(上市公司)发布2025年度报告,新任首席执行官正式上任,标志着公司国际扩张战略进入新阶段。
第四季度净销售额达到1830万瑞典克朗,较上年同期的1720万瑞典克朗实现增长。当季运营业绩为亏损1020万瑞典克朗,相比去年同期亏损1370万瑞典克朗明显收窄。
Enzymatica AB(上市公司)发布2025年度报告,新任首席执行官正式上任,标志着公司国际扩张战略进入新阶段。
第四季度净销售额达到1830万瑞典克朗,较上年同期的1720万瑞典克朗实现增长。当季运营业绩为亏损1020万瑞典克朗,相比去年同期亏损1370万瑞典克朗明显收窄。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.